Create Alert
Watchlist

Ortin Global

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹11Cr
ROE-42.80%
P/E Ratio(TTM)-11.90
EPS(TTM)-1.13
P/B Ratio5.52
Dividend Yield0.00%
Industry P/E40.09
Book Value2.44
Debt to Equity0.13
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Ortin Global

Ortin Laboratories Limited is engaged in manufacturing and trading of pharmaceuticals, drugs, and intermediates. It manufactures a range of pharmaceutical formulations of tablets, capsules, syrups, and dry powders. The Company's products include Acefinac, ACEFINAC-CZ, ACEFINAC-P, ACEFINAC-SP, ACTAZID, ACTY-P, ALERFEX-120, ALERFEX-180, ALERGID, ALERGID- L, AMLOBID, CARBAMOL, CARISNIL, CALDY-C AZITIN-500, DOCEF-200, GLYCITROL, GLYCITROL-M, LORACT, MEBOL, NEUROCOB, FERUP, IRFER Z, MINVITA-B, NILCID, ORICILLIN-DX, PEG POWDER, PEG-D POWDER, ALKASIT, COF-XL, DECODIL, ENCENIL and OROMOX DRY SYRUP. Its formulations include Anti Diabetics, Anti Allergics, Anti Anginal and Cardiovascular, Analgesics and Antipyretics, and Anti Biotics-Quinolones. Its active pharmaceutical ingredient (API) intermediates include Anti retro viral, Grignard, Diborane, Ciprofloxacin and Tramadol. It is also manufacturing for different importers to market their products in Russia, Ukraine, Kajakistan and South America.;
Parent OrganisationOrtin Global
Managing DirectorShri. Sanka Krishna Murthy
NSE SymbolORTINGLOBE

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Retail And Others
92.24%
Foreign Institutions
6.53%
Promoters
1.23%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
102.99
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.31
Emcure Pharmaceuticals
NA
(0.00%)
34.88
Wockhardt
NA
(0.00%)
-194.91